Researchers analyzing millions of safety reports identified a possible link between a popular obesity drug…
Browsing: Semaglutide
Semaglutide is a medication primarily used to treat type 2 diabetes and obesity. It belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the action of the naturally occurring hormone GLP-1 to increase insulin secretion, reduce appetite, and slow down digestion. This helps in better blood sugar control and weight loss. Semaglutide is available in injectable forms and as an oral tablet, and it has been shown in clinical trials to be highly effective in improving glycemic control and aiding significant weight loss, making it a valuable option for managing these conditions.
Weight loss treatments do more than reduce weight, they subtly alter body composition, raising new…
A new clinical trial is exploring a different strategy for tackling one of obesity treatment’s…
New research suggests the risks tied to early pregnancy exposure to popular weight loss drugs…
A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve…
A new study suggests that a common menopause treatment may influence how effectively certain weight-loss…
A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1…
A new animal study raises important questions about a little-known ingredient used in oral weight-loss…
New research suggests that people using next-generation weight loss drugs may be losing weight without…
Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may…
Semaglutide may safeguard the heart even without significant weight loss. A new study led by…
Drugs used for diabetes and weight loss may also dampen alcohol’s effects by slowing how…
As GLP-1 weight-loss drugs become more common, their effects may be reshaping everyday food choices…
GLP-1 drugs like Ozempic, Trulicity and Victoza were associated with a slightly lower likelihood of…
In addition to reducing hunger, popular weight-loss drugs also affect reward processing and motivated behaviors.…
GLP-1 drugs may protect the liver but raise blood alcohol levels. Yale researchers are investigating…
New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major…
Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss,…